May 23, 2005 — The European Commission has approved a 50-mg/mL formulation of etanercept injection for the treatment of rheumatoid arthritis, and the U.K.'s Medicine and Healthcare Products Regulatory ...
A new biosimilar generic alternative to the multibillion blockbuster Enbrel could hit pharmacy shelves next year. A bit of background Amgen and Pfizer's Enbrel is approved to treat common autoimmune ...
April 15, 2004 — The U.S. Food and Drug Administration (FDA) has approved an intravenous formulation of pantoprazole sodium, a cardioverter defibrillator system, and a first-time generic for ribavirin ...